3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
5
Fallopian Tube Neoplasms
4
Peritoneal Neoplasms
3
Hyperthermia
3
Carcinoma, Ovarian Epithelial
3
Recurrence
1
Mesothelioma
1
Gastrointestinal Neoplasms
1
Colonic Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinoma, Renal Cell
1
Carcinoma
1
Brenner Tumor
1
Appendiceal Neoplasms
1
Adrenocortical Carcinoma
1
Abdominal Neoplasms
1
Interventions
Gemcitabine
14
Cisplatin
13
Capecitabine
11
Oxaliplatin
9
Fluorouracil
9
130-nm albumin-bound paclitaxel
9
Paclitaxel
8
pembrolizumab
7
Ramucirumab
6
Leucovorin
6
Carboplatin
6
Bevacizumab
6
Albumin-Bound Paclitaxel
6
Pemetrexed
4
Nivolumab
4
Irinotecan
4
Everolimus
4
Erlotinib Hydrochloride
4
Docetaxel
4
Cyclophosphamide
4
trastuzumab deruxtecan
3
Radiotherapy
3
Afatinib
3
zolbetuximab
2
pralsetinib
2
cabozantinib
2
Trastuzumab
2
Ipilimumab
2
vosaroxin
1
vandetanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma
×
Cytoreduction Surgical Procedures
×
Clear all
No trials found.